GWPH - GW Pharmaceuticals EPS misses by $0.03 beats on revenue February, 25 2020 04:03 PM GW Pharmaceuticals Plc GW Pharmaceuticals (NASDAQ:GWPH): Q4 GAAP EPS of -$0.07 misses by $0.03.Revenue of $109.1M beats by $4.78M.Press ReleaseMore news on: GW Pharmaceuticals plc, Earnings news and commentary, Healthcare stocks news,